Elephas Announces Commercial Partnership with Invitrocue to Expand Personalized Oncology in Southeast Asia
Elephas Biosciences Corporation has announced an international partnership with Invitrocue to introduce its elive™ platform in Singapore and Malaysia, strengthening the development of personalized oncology solutions across Southeast Asia. Madison, Wisconsin — July 21, 2026 Elephas Biosciences Corporation, a private company that has developed an innovative live tissue platform for immunotherapy response prediction, has announced …